Department of Dermatology, Chi Mei Medical Center, Tainan, Taiwan.
Division of Hematology-Oncology, Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Medicine (Baltimore). 2023 Feb 3;102(5):e32797. doi: 10.1097/MD.0000000000032797.
Melanoma is a life-threatening form of skin cancer. Due to its remarkable effectiveness, the immune checkpoint blockade is widely used to treat melanoma (ICBM). No research has been conducted on ICBM for identifying the most readable articles. A bibliometric analysis of 100 top-cited ICBM (T100ICBM) in recent decades is required to highlight articles worth reading.
Based on the Web of Science Core Collection, we summarized the articles on ICBM published in each year from 2000 to 2022, with first authors from Mainland China, Hong Kong, and Taiwan (CHT). Using the CJAL score, data extraction and visualization of the distribution of ICBM publications were conducted on 2718, and 100 top-cited articles, respectively. We used the temporal heatmap to identify the most readable articles. Four descriptive, diagnostic, predictive, and prescriptive analytics (called DDPP model) were applied to describe the features of T100ICBM articles. The absolute advantage coefficient was used to determine the dominance extent of the most influential region, institute, department, and author.
A total of 2718 publications was included after removing first or corresponding authors who were not affiliated with CHT. Publications by year showed a sharp increase from 2014 onward and either peaked in 2022 or have not yet peaked. It was evident that there was a large difference between the number of publications in provinces/metropolitan cities/regions on CHT. Beijing, Sichuan University, Oncology, and Guo Jun from Beijing are the most prolific and influential region, institute, department, and author. When comparing research achievements to the next productive authors based on the CJAL score, only Dr Jun has a medium effect of dominance (=0.60). On the basis of their consecutive growth in citations over the past 4 years, 20 T100ICBM articles were recommended for readers.
The field of ICBM is growing rapidly, and Beijing and Sichuan University are taking the lead in CHT. Furthermore, the study provides references for worth-reading articles using the temporal heatmap. Future research hot spots may focus on these 4 themes of immunotherapy, melanoma, metastatic melanoma, regulatory T cells, cells, and activation, which may pave the way for additional study.
黑色素瘤是一种危及生命的皮肤癌。由于其显著的疗效，免疫检查点阻断被广泛用于治疗黑色素瘤（ICBM）。目前还没有研究针对 ICBM 来识别最易读的文章。因此，需要对近几十年来的 100 篇顶级 ICBM （T100ICBM）进行文献计量分析，以突出值得阅读的文章。
我们基于 Web of Science 核心合集，总结了 2000 年至 2022 年期间，来自中国大陆、香港和台湾（CHT）的第一作者发表的关于 ICBM 的文章。使用 CJAL 评分，分别对 2718 篇和 100 篇高被引文章进行了数据提取和可视化分布。使用时间热图来识别最易读的文章。我们应用了四种描述性、诊断性、预测性和规范性分析（称为 DDPP 模型）来描述 T100ICBM 文章的特征。绝对优势系数用于确定最具影响力的地区、机构、部门和作者的优势程度。
在排除了不是 CHT 附属的第一作者或对应作者后，共纳入 2718 篇出版物。按年份发表的出版物数量从 2014 年开始急剧增加，要么在 2022 年达到峰值，要么尚未达到峰值。显然，CHT 各省市/自治区的出版物数量存在很大差异。北京、四川大学、肿瘤学和北京的郭军是最具生产力和影响力的地区、机构、部门和作者。根据 CJAL 评分与下一位高产作者的研究成果比较，只有郭军博士具有中等程度的优势度（=0.60）。根据过去 4 年引文的连续增长，推荐了 20 篇 T100ICBM 文章供读者阅读。
ICBM 领域发展迅速，北京和四川大学在 CHT 中处于领先地位。此外，该研究还通过时间热图为易读文章提供了参考。未来的研究热点可能集中在免疫疗法、黑色素瘤、转移性黑色素瘤、调节性 T 细胞、细胞和激活这 4 个主题上，这可能为进一步的研究铺平道路。
